missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. uPAR Antibody (VIM-5), Novus Biologicals™
  7. 18669358

uPAR Antibody (VIM-5), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-11408-0.025mg

 View more versions of this product

Product Code. 18669358

  • 201.00 € / 25µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

uPAR Monoclonal antibody specifically detects uPAR in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Frozen)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

uPAR
Monoclonal
Unconjugated
PBS
Mouse
Protein G purified
RUO
Primary
Human
Purified
Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Frozen)
VIM-5
Flow Cytometry 1:50 - 1:200, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Frozen 1:100
CD87, CD87 antigen, Monocyte activation antigen Mo3, plasminogen activator, urokinase receptor, uPAR, U-PAR, UPARurokinase plasminogen activator surface receptor, u-plasminogen activator receptor form 2, URKRMO3
THP-1 cells (Human acute monocytic leukaemia cells).
0.025 mg
Cancer
5329
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.